Sign inJoin waitlistJoin the waitlist

LH

Leora Horn

Medical Oncology

Credentials: · · ·

History

Hematology and Medical Oncology
2005–2008
Internal Medicine
2002–2005
Doctor of Medicine
1998–2002

Research

Safety, activity, and immune correlates of anti-PD-1 antibody in cancer
New England Journal of Medicine · 2012 · 10,404 citations
Nivolumab versus Docetaxel in Advanced Nonsquamous Non-Small-Cell Lung Cancer
New England Journal of Medicine · 2015 · 7,953 citations
Pembrolizumab for the treatment of non-small-cell lung cancer
New England Journal of Medicine · 2015 · 5,237 citations

Christine Lovly
19 papers · 2 as a fellow
DS
David Spigel
19 papers
Karen Reckamp
18 papers
Jyoti Patel
17 papers
Ramaswamy Govindan
17 papers
Heather Wakelee
16 papers
Hossein Borghaei
16 papers
Scott Gettinger
16 papers
GO
Gregory Otterson
15 papers
GR
Gregory Riely
14 papers
Ross Camidge
14 papers
Wallace Akerley
14 papers

Clinical trials

Pemetrexed Disodium and Carboplatin or Cisplatin With or Without Erlotinib Hydrochloride in Treating Patient With Stage IV Non-Small Cell Lung Cancer Resistant to First-Line Therapy With Erlotinib Hydrochloride or Gefitinib
Principal investigator · Withdrawn · Phase 2
Vanderbilt-Ingram Cancer Center
2014–2015
Low-Dose Acetylsalicylic Acid in Treating Patients With Stage I-III Non-Small Cell Lung Cancer
Principal investigator · Terminated · Early phase 1
Vanderbilt-Ingram Cancer Center
2012–2018
Bendamustine as Second-Line Therapy in Treating Patients With Relapsed or Refractory Small Cell Lung Cancer
Principal investigator · Completed · Phase 2
Vanderbilt-Ingram Cancer Center
2009–2012
Irinotecan and Carboplatin as First-Line Therapy in Treating Patients With Extensive-Stage Small Cell Lung Cancer
Principal investigator · Completed · Phase 2
Vanderbilt-Ingram Cancer Center
2003–2010